Sponsor or institution
Clinical trials and research at Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
As of November 12, 2026, Find a Trial lists 23 clinical trials run by Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. that are recruiting, in China. By phase: Phase 1 (12), Phase 3 (5), Phase 2 (3), Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 23Clinical trials
- 1Country
Newest trials
All recruiting trials (23)
-
HDM2017 combination therapy in advanced colorectal cancer
A small and mid-size study tests HDM2017 with standard chemotherapy and targeted drugs to see if it’s safe and may help people with unresectable or metastatic colorectal cancer.
-
HDM2020 in advanced squamous NSCLC
A new drug called HDM2020 is being tested to see if it is safe and can help people with advanced squamous non-small cell lung cancer who have tried other treatments.
-
HDM1002 tablets and heart rhythm in healthy adults
A single-dose test of HDM1002 (200 mg and 400 mg) is being tried in healthy adults to see if it changes the QT/QTc interval on ECG.
-
HDM2024 for people with advanced solid tumors
This trial will test HDM2024 to see if it's safe and can shrink tumors in adults with advanced solid cancers who have progressed after or cannot tolerate standard treatments.
-
HDP-101 for relapsed or refractory multiple myeloma in Chinese patients
This trial will try HDP-101 to see if it is safe and can help control relapsed or refractory multiple myeloma in Chinese adults.
-
HDM1005 versus tirzepatide for weight loss in adults with obesity
This 56-week test will see if weekly HDM1005 at three dose levels helps adults with obesity but without diabetes lose more weight than weekly tirzepatide while all participants receive lifestyle counseling.
-
HDM1005 injections for adults with type 2 diabetes not controlled by diet and exercise
This trial will test whether HDM1005 injections help adults with type 2 diabetes whose blood sugar isn't controlled by diet and exercise alone.
-
Testing HDM2006 in adults with advanced solid tumors
This will test a new medicine called HDM2006 to see if it is safe and can help adults with advanced or metastatic solid tumors who have run out of standard treatment options.
-
How HDM1002 interacts with metformin, empagliflozin, midazolam, valsartan, and warfarin in overweight adults
This trial tests how the investigational drug HDM1002 affects and is affected by metformin, empagliflozin, midazolam, valsartan, and warfarin in overweight adults.
-
HDM1005 for non-diabetic Chinese adults with overweight or obesity
This trial will test whether once-weekly HDM1005 helps Chinese adults who are overweight or have obesity but do not have diabetes lose weight and remain safe over one year.
-
Phase 1 HDM2017 for advanced solid tumors
This trial will test an experimental drug called HDM2017 in adults with advanced solid tumors to see if it is safe and has any anti-tumor activity.
-
Metformin plus SGLT‑2 inhibitor and GLP‑1 receptor agonist triple therapy for poorly controlled type 2 diabetes
This trial will see if adding an SGLT‑2 inhibitor and a GLP‑1 receptor agonist to metformin improves blood sugar control in adults with type 2 diabetes who have poor glycemic control.
-
HDM1002 tablets for adults with type 2 diabetes
This study will test whether once-daily HDM1002 tablets can help lower blood sugar in adults with type 2 diabetes who are managing their condition with diet and exercise only.
-
HDM2005 combined with standard treatment for diffuse large B-cell lymphoma.
We are testing whether adding HDM2005 to standard chemotherapy helps adults with diffuse large B‑cell lymphoma who are either newly diagnosed or whose disease has returned.
-
HDM1005 for adults with Type 2 diabetes not controlled by diet/exercise or metformin
This trial will test different doses of HDM1005 versus placebo and dulaglutide in adults with Type 2 diabetes whose blood sugar isn't controlled by diet/exercise or metformin.
-
HDM2012 for advanced solid tumors
This first-in-human study will try HDM2012, an experimental drug, in adults with advanced solid tumors to check safety and early signs of benefit.
-
HDM2020 for people with advanced solid tumors
This study will test whether the experimental drug HDM2020 is safe and can shrink tumors in adults with advanced FGFR2-expressing solid tumors.
-
HDM1002 tablets to lower blood sugar in adults with type 2 diabetes
This study will test whether daily HDM1002 tablets lower blood sugar more effectively than dapagliflozin in adults with type 2 diabetes who are not controlled on metformin.
-
Semaglutide injection versus WEGOVY® for weight loss in Chinese adults with obesity
This 48-week test compares a semaglutide injection made by Hangzhou Zhongmei with WEGOVY® to see if it helps Chinese adults with obesity lose weight and is similarly safe.
-
HDM2005 for advanced solid tumors
This trial will test whether HDM2005 is safe and has anti-tumor activity in adults with metastatic solid tumors that have progressed after prior treatments.
-
Evaluating the effects of hepatic impairment on HDM1002
This study tests how different levels of liver function affect the way the drug HDM1002 works in Chinese adults aged 18-70.
-
Evaluating HDM1005 injection for weight loss in obese adults without diabetes
This study is testing if an injection called HDM1005 can help obese adults without diabetes lose weight and improve their health.
-
Evaluating HDM2005 for patients with relapsed B-cell lymphoma and advanced solid tumors
This study is testing a new drug called HDM2005 to see if it can help people with relapsed B-cell lymphoma and advanced solid tumors feel better.
Quick answers
How many clinical trials run by Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. are recruiting right now?
23, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 12, Phase 3: 5, Phase 2: 3, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.